Benzinga | Dec 14, 2020 06:21AM EST

SVB Leerink Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $175

SVB Leerink analyst Richard Newitter maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and raises the price target from $167 to $175.